Analgesics in Argentina
Although loyalty towards long-established consumer health brands, especially OTC products, remains relatively high among Argentinians, there has been a noticeable shift towards more affordable generic products. This trend was fuelled by multiple factors, including the economic crisis, low entry barriers, a lack of supervision from the National Administration of Medicine, Nutrition and Medical Technology (ANMAT) and a series of initiatives, mostly from domestic generics manufacturers, to communic...
Euromonitor International's Analgesics in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Analgesics in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Prospects
Value-priced Positioning of Generics Driving Sales of These Products
Adult Acetaminophen Benefiting From Genomma's Investments
Topical Analgesics Continues To Be Slightly More Dynamic Than Systemic Analgesics
Competitive Landscape
Genomma Laboratories Investing in Tafirol Forte and Next and Also Launches Tafirol Plus
Leader Bayer Argentina Helps Drive Sales Through Downsizing Its Aspirin Packs
Players Moving Towards Stronger Doses of Ibuprofen, Aspirin and Paracetamol
Category Data
Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Executive Summary
Consumer Health Still Growing, But at Slower Rates in 2019
Consumer Health Expenditure Continues Increasing
No Change at the Top, As Bayer, Arcor and Abbott Continue To Lead
Direct Selling Performing Well Against the Backdrop of High Inflation Rates
Further Growth Expected in Consumer Health Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
Prospects
Value-priced Positioning of Generics Driving Sales of These Products
Adult Acetaminophen Benefiting From Genomma's Investments
Topical Analgesics Continues To Be Slightly More Dynamic Than Systemic Analgesics
Competitive Landscape
Genomma Laboratories Investing in Tafirol Forte and Next and Also Launches Tafirol Plus
Leader Bayer Argentina Helps Drive Sales Through Downsizing Its Aspirin Packs
Players Moving Towards Stronger Doses of Ibuprofen, Aspirin and Paracetamol
Category Data
Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Executive Summary
Consumer Health Still Growing, But at Slower Rates in 2019
Consumer Health Expenditure Continues Increasing
No Change at the Top, As Bayer, Arcor and Abbott Continue To Lead
Direct Selling Performing Well Against the Backdrop of High Inflation Rates
Further Growth Expected in Consumer Health Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
